Dr. Chevon Rariy

CTCA Telehealth Program Director Cancer Treatment Centers of America

• Dr. Rariy is an Endocrinologist with a focus on Endocrine Oncology, Double Board certified in Internal medicine and Endocrinology, Diabetes and Metabolism;

• Fellowship trained at Harvard Medical School’s affiliate Brigham & Women’s Hospital and University of Pittsburgh Medical Center (UPMC), with a medical degree from Harvard Medical School

• 20+ presentations at national conferences, including presenting on Oncology and Telehealth at the FDA Center for Excellence in Oncology and publications in peer-reviewed journals, including the New England Journal of Medicine and Becker’s Hospital Review

• National Program Director of Telehealth at Cancer Treatment Centers of America (CTCA) and Medical Director of Endocrinology

• Over 15 years of telehealth experience and most recently led the rapid scale up and implementation of a national telehealth program within an oncology health system network that lead to an 80 fold increase in utilization, total ~8,000 telehealth visits in 4 weeks

• Additionally, she has spearheaded the launch of rural health tele-oncology program promoting a coordinated care approach between a national cancer center and rural hospitals

• Dr. Rariy has won numerous awards for her work in clinical research, and most recently, the CTCA Chairman’s Award for her contributions in telehealth

• She sits on a number of Advisory Boards, including Doximity, online physician networking firm where membership includes more than for 70% of US physicians and a personalized remote patient monitoring/digital therapeutics firm and Association of Community Cancer Centers (ACCC) Telehealth Advisory Board